S. Pavlovic, Intravenous immunoglobulins exposed to heme (heme IVIG) are more efficient than IVIG in attenuating autoimmune diabetes, Clinical Immunology, vol.138, issue.2, pp.162-71, 2011.
DOI : 10.1016/j.clim.2010.10.010

J. Dimitrov, Ferrous Ions and Reactive Oxygen Species Increase Antigen-binding and Anti-inflammatory Activities of Immunoglobulin G, Journal of Biological Chemistry, vol.281, issue.1, pp.439-485, 2006.
DOI : 10.1074/jbc.M509190200

J. Dimitrov, Antibodies Use Heme as a Cofactor to Extend Their Pathogen Elimination Activity and to Acquire New Effector Functions, Journal of Biological Chemistry, vol.282, issue.37, pp.26696-706, 2007.
DOI : 10.1074/jbc.M702751200

J. Mcintyre, D. Wagenknecht, and W. Faulk, Redox-reactive autoantibodies: Detection and physiological relevance, Autoimmunity Reviews, vol.5, issue.1, p.76, 2006.
DOI : 10.1016/j.autrev.2005.07.009

I. Djoumerska-alexieva, J. Dimitrov, J. Nacheva, S. Kaveri, and T. Vassilev, Protein destabilizing agents induce polyreactivity and enhanced immunomodulatory activity in IVIg preparations, Autoimmunity, vol.57, issue.4, pp.365-372, 2009.
DOI : 10.1056/NEJMra993360

W. Hubbard, CECAL LIGATION AND PUNCTURE, Shock, vol.24, issue.Supplement 1, pp.52-59, 2005.
DOI : 10.1097/01.shk.0000191414.94461.7e

DOI : 10.1097/01.shk.0000155350.95435.28

N. Ivanovska, Properdin Deficiency in Murine Models of Nonseptic Shock, The Journal of Immunology, vol.180, issue.10, pp.6962-6971, 2008.
DOI : 10.4049/jimmunol.180.10.6962

N. Haeffner-cavaillon, M. Klein, and K. Dorrington, Studies on the Fc gamma receptor of the murine macrophage-like cell line P388D1. I. The binding of homologous and heterologous immunoglobulin G1, J. Immunol, vol.123, pp.1905-1918, 1979.

P. Ward and H. Gao, Sepsis, complement and the dysregulated inflammatory response, Journal of Cellular and Molecular Medicine, vol.8, issue.10, pp.4154-60, 2009.
DOI : 10.1111/j.1582-4934.2009.00893.x

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087605

M. Markiewski, R. Deangelis, and J. Lambris, Complexity of complement activation in sepsis, Journal of Cellular and Molecular Medicine, vol.4, issue.6a, pp.2245-54, 2008.
DOI : 10.1111/j.1582-4934.2008.00504.x

J. Xu, Extracellular histones are major mediators of death in sepsis, Nature Medicine, vol.13, issue.11, pp.1318-1339, 2009.
DOI : 10.1038/nm.2053

M. Basta, Ambivalent effect of immunoglobulins on the complement system: Activation versus inhibition, Molecular Immunology, vol.45, issue.16, pp.4073-4082, 2008.
DOI : 10.1016/j.molimm.2008.07.012

M. Basta, L. Fries, and M. Frank, High doses of intravenous Ig inhibit in vitro uptake of C4 fragments onto sensitized erythrocytes, Blood, vol.77, pp.376-80, 1991.

O. Devran, C-reactive protein as a predictor of mortality in patients affected with severe sepsis in intensive care unit, Multidisciplinary Respiratory Medicine, vol.7, issue.1, pp.47-52, 2012.
DOI : 10.1097/00003246-200203000-00006

B. Tang, S. Huang, and A. Mclean, Genome-wide transcription profiling of human sepsis: a systematic review, Critical Care, vol.14, issue.6, p.237, 2010.
DOI : 10.1186/cc9392

A. Coutinho and S. Avrameas, Speculations on Immunosomatics: Potential Diagnostic and Therapeutic Value of Immune Homeostasis Concepts, Scandinavian Journal of Immunology, vol.88, issue.4, pp.527-559, 1992.
DOI : 10.1016/0090-1229(75)90087-2

J. Cavaillon and M. Adib-conquy, Determining the Degree of Immunodysregulation in Sepsis, Contrib. Nephrol, vol.156, pp.101-112, 2007.
DOI : 10.1159/000102075

D. Angus and T. Van-der-poll, Severe Sepsis and Septic Shock, New England Journal of Medicine, vol.369, issue.9, pp.840-51, 2013.
DOI : 10.1056/NEJMra1208623

I. The and . Group, Treatment of neonatal sepsis with intravenous immune globulin, N. Engl. J. Med, vol.365, pp.1201-1212, 2011.

D. Rittirsch, M. Flierl, and P. Ward, Harmful molecular mechanisms in sepsis, Nature Reviews Immunology, vol.1537, issue.10, pp.776-87, 2008.
DOI : 10.1097/01.shk.0000225403.15722.e9

J. Bouvet, Induction of Natural Autoantibody Activity Following Treatment of Human Immunoglobulin with Dissociating Agents, Journal of Autoimmunity, vol.16, issue.2, 2001.
DOI : 10.1006/jaut.2000.0472

W. Xiao, A genomic storm in critically injured humans, The Journal of Experimental Medicine, vol.61, issue.13, pp.2581-90, 2011.
DOI : 10.1038/nature08780

M. Kazatchkine and S. Kaveri, Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin, N. Engl. J. Med, vol.345, pp.747-55, 2001.

H. Lutz, c2012) Naturally Occurring Antibodies (NAbs, Austin) TX: Landes Bioscience, p.267

K. Laupland, A. Kirkpatrick, and A. Delaney, Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: A systematic review and meta-analysis*, Critical Care Medicine, vol.35, issue.12, pp.2686-92, 2007.
DOI : 10.1097/01.CCM.0000295312.13466.1C

M. Soares, An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis., Health Technology Assessment, vol.16, issue.7, pp.1-186, 2012.
DOI : 10.3310/hta16070

K. Werdan, Score-based immunoglobulin G therapy of patients with sepsis: The SBITS study*, Critical Care Medicine, vol.35, issue.12, pp.2693-701, 2007.
DOI : 10.1097/01.CCM.0000295426.37471.79

I. Djoumerska, A. Tchorbanov, A. Pashov, and T. Vassilev, The Autoreactivity of Therapeutic Intravenous Immunoglobulin (IVIg) Preparations Depends on the Fractionation Methods Used, Scandinavian Journal of Immunology, vol.26, issue.4, pp.357-63, 2005.
DOI : 10.1111/j.1600-0609.2004.00350.x

I. Djoumerska-alexieva, Exposure of IgG to an acidic environment results in molecular modifications and in enhanced protective activity in sepsis, FEBS Journal, vol.420, issue.14, pp.3039-50, 2010.
DOI : 10.1111/j.1742-4658.2010.07714.x

G. Sigounas, N. Harindranath, G. Donadel, and A. Notkins, Half-life of polyreactive antibodies, Journal of Clinical Immunology, vol.20, issue.2, pp.134-174, 1994.
DOI : 10.1007/BF01541346

P. Matzinger, The Danger Model: A Renewed Sense of Self, Science, vol.296, issue.5566, pp.301-306, 2002.
DOI : 10.1126/science.1071059

S. Seong and P. Matzinger, Opinion: Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses, Nature Reviews Immunology, vol.29, issue.6, pp.469-78, 2004.
DOI : 10.1126/science.285.5430.1058

P. Rauch, Innate Response Activator B Cells Protect Against Microbial Sepsis, Science, vol.335, issue.6068, pp.597-601, 2012.
DOI : 10.1126/science.1215173

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3279743

I. Djoumerska-alexieva, S. Pashova, T. Vassilev, and A. Pashov, The protective effect of modified intravenous immunoglobulin in LPS sepsis model is associated with an increased IRA B cells response, Autoimmunity Reviews, vol.12, issue.6, pp.653-659, 2013.
DOI : 10.1016/j.autrev.2012.10.010

J. Seok, Genomic responses in mouse models poorly mimic human inflammatory diseases, Proceedings of the National Academy of Sciences, vol.110, issue.9, pp.3507-3519, 2013.
DOI : 10.1073/pnas.1222878110

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3587220

K. Takao and T. Miyakawa, Genomic responses in mouse models greatly mimic human inflammatory diseases, Proceedings of the National Academy of Sciences, vol.112, issue.4, pp.1167-72, 2015.
DOI : 10.1073/pnas.1401965111